Abstract

Safety and Efficacy in the Stratus (MM-010) Trial, a Single-Arm Phase 3b Study Evaluating Pomalidomide + Low-Dose Dexamethasone in Patients with Refractory or Relapsed and Refractory Multiple Myeloma

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Efficacy and Safety Of Pomalidomide Plus Low-Dose Dexamethasone In Advanced Multiple Myeloma: Results Of Randomized Phase 2 and 3 Trials (MM-002/MM-003)
David S Siegel ...
Blood | VOL. 122
David S Siegel, et. al.David S Siegel ...
15 Nov 2013
Randomized, Open Label Phase 1/2 Study of Pomalidomide (POM) Alone or in Combination with Low-Dose Dexamethasone (LoDex) in Patients (Pts) with Relapsed and Refractory Multiple Myeloma Who Have Received Prior Treatment That Includes Lenalidomide (LEN) and Bortezomib (BORT): Phase 2 Results
Paul G Richardson ... Kenneth C Anderson
Blood | VOL. 118
Paul G Richardson, et. al.Paul G Richardson ... Kenneth C Anderson
18 Nov 2011
A Phase 1, Multicenter Study of Pomalidomide, Bortezomib, and Low-Dose Dexamethasone in Patients with Proteasome Inhibitor Exposed and Lenalidomide-Refractory Myeloma (Trial MM-005)
Paul G Richardson ... Kenneth C Anderson
Blood | VOL. 126
Paul G Richardson, et. al.Paul G Richardson ... Kenneth C Anderson
03 Dec 2015
Pomalidomide + Bortezomib + Low-Dose Dexamethasone Vs Bortezomib + Low-Dose Dexamethasone As Second-Line Treatment in Patients with Lenalidomide-Pretreated Multiple Myeloma: A Subgroup Analysis of the Phase 3 Optimismm Trial
Meletios A Dimopoulos ... Paul Richardson
Blood | VOL. 132
Meletios A Dimopoulos, et. al.Meletios A Dimopoulos ... Paul Richardson
29 Nov 2018
View more papers

More From: Blood

Paper Title
Journal
Date
Author
CRISPR-based rapid molecular diagnostic tests for fusion-driven leukemias.
Rahul S Vedula ... R Coleman Lindsley
Blood | VOL. -
Rahul S Vedula, et. al.Rahul S Vedula ... R Coleman Lindsley
08 Jul 2024
Low-intensity transcranial focused ultrasound suppresses pain by modulating pain processing brain circuits.
Min Gon Kim ... Bin He
Blood | VOL. -
Min Gon Kim, et. al.Min Gon Kim ... Bin He
08 Jul 2024
How I Treat: Differentiation Therapy in Acute Myeloid Leukemia.
Ghayas C Issa ... Courtney D D Dinardo
Blood | VOL. -
Ghayas C Issa, et. al.Ghayas C Issa ... Courtney D D Dinardo
08 Jul 2024
Single-cell genomics details the maturation block in BCP-ALL and identifies therapeutic vulnerabilities in DUX4-r cases.
Hanna Thorsson ... Thoas Fioretos
Blood | VOL. -
Hanna Thorsson, et. al.Hanna Thorsson ... Thoas Fioretos
05 Jul 2024
View more papers